PExA Overview
- Year Founded
-
2002
- Status
-
Public
- Employees
-
3
- Stock Symbol
-
PEXA B
- Share Price
-
$0.04
- (As of Monday Closing)
PExA General Information
Description
PExA AB develops, manufactures, and markets a research tool for studying respiratory diseases, including asthma and chronic obstructive pulmonary disease (COPD). Its product includes PExA 2.0.
Contact Information
Website
www.pexa.seCorporate Office
- Erik Dahlbergsgatan 11 A
- Floor 2, South East
- 411 26 Gothenburg
- Sweden
Corporate Office
- Erik Dahlbergsgatan 11 A
- Floor 2, South East
- 411 26 Gothenburg
- Sweden
PExA Stock Performance
(As of Monday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.04 | $0.04 | $0.03 - $0.06 | $2.48M | 58.2M | 71.5K | -$0.02 |
PExA Financials Summary
In Thousands, USD |
TTM 30-Jun-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
---|---|---|---|---|
EV | 821 | 648 | 770 | 3,035 |
Revenue | 123 | 190 | 594 | 252 |
EBITDA | (856) | (763) | (379) | (770) |
Net Income | (825) | (757) | (424) | (903) |
Total Assets | 996 | 1,515 | 2,386 | 2,907 |
Total Debt | 0 | 0 | 0 | 0 |
PExA Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
PExA Patents
PExA Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4426193-A1 | A device and method for determining a respiratory system infection from exhaled breath | Pending | 02-Nov-2021 | 00000000 | |
EP-4327068-A1 | A sample preparation device | Pending | 19-Apr-2021 | 000000000 | |
JP-2024516381-A | Sample preparation device | Pending | 19-Apr-2021 | 000000000 | |
US-20240210286-A1 | A sample preparation device | Pending | 19-Apr-2021 | 000000000 | |
EP-3651642-B1 | New system for collecting exhaled particles | Active | 10-Jul-2017 | A61B5/097 |
PExA Executive Team (4)
Name | Title | Board Seat |
---|---|---|
Erik Ekbo | Chief Executive Officer | |
Anna-Carin Olin Ph.D | Founder & Board Member | |
Svante Höjer Ph.D | Manager, Engineering and Design | |
Tomas Gustafsson | Chief Executive Officer |
PExA Board Members (5)
Name | Representing | Role | Since |
---|---|---|---|
Anna-Carin Olin Ph.D | PExA | Founder & Board Member | 000 0000 |
Bertil Larsson | Self | Board Member | 000 0000 |
Claes Holmberg Ph.D | Self | Chairman of the Board | 000 0000 |
Klementina Österberg | Self | Board Member | 000 0000 |
PExA Signals
PExA Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
PExA FAQs
-
When was PExA founded?
PExA was founded in 2002.
-
Who is the founder of PExA?
Anna-Carin Olin Ph.D is the founder of PExA.
-
Who is the CEO of PExA?
Erik Ekbo and Tomas Gustafsson are the CEOs of PExA.
-
Where is PExA headquartered?
PExA is headquartered in Gothenburg, Sweden.
-
What is the size of PExA?
PExA has 3 total employees.
-
What industry is PExA in?
PExA’s primary industry is Diagnostic Equipment.
-
Is PExA a private or public company?
PExA is a Public company.
-
What is PExA’s stock symbol?
The ticker symbol for PExA is PEXA B.
-
What is the current stock price of PExA?
As of 16-Sep-2024 the stock price of PExA is $0.04.
-
What is the current market cap of PExA?
The current market capitalization of PExA is $2.48M.
-
What is PExA’s current revenue?
The trailing twelve month revenue for PExA is $123K.
-
What is PExA’s annual earnings per share (EPS)?
PExA’s EPS for 12 months was -$0.02.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »